Thrivent Financial For Lutherans Legend Biotech Corp Transaction History

Thrivent Financial For Lutherans

  • $51.6 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$43.55 - $59.88 $1.46 Million - $2.01 Million
33,585 Added 38.26%
121,377 $5.92 Million
Q2 2024

Aug 13, 2024
SELL
$39.5 - $57.22 $1.23 Million - $1.78 Million
-31,053 Reduced 26.13%
87,792 $3.89 Million
Q1 2024

May 14, 2024
BUY
$55.06 - $69.99 $6.54 Million - $8.32 Million
118,845 New
118,845 $6.67 Million

Others Institutions Holding LEGN

# of Institutions
232
Shares Held
86.1M
Call Options Held
260K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.81B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email